J. Safra Sarasin Holding AG Sells 39,952 Shares of Agilent Technologies, Inc. $A

J. Safra Sarasin Holding AG trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 18.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 180,319 shares of the medical research company’s stock after selling 39,952 shares during the quarter. J. Safra Sarasin Holding AG owned 0.06% of Agilent Technologies worth $24,536,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Wellington Management Group LLP increased its stake in Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after acquiring an additional 433,342 shares during the last quarter. Generation Investment Management LLP lifted its stake in shares of Agilent Technologies by 10.1% in the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after purchasing an additional 582,093 shares during the last quarter. Norges Bank purchased a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $395,088,000. Ameriprise Financial Inc. boosted its holdings in shares of Agilent Technologies by 15.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,708,591 shares of the medical research company’s stock worth $347,685,000 after purchasing an additional 354,480 shares during the period. Finally, Troy Asset Management Ltd increased its position in shares of Agilent Technologies by 0.3% during the 3rd quarter. Troy Asset Management Ltd now owns 2,404,161 shares of the medical research company’s stock valued at $308,574,000 after purchasing an additional 6,341 shares during the last quarter.

Agilent Technologies Price Performance

Shares of A stock opened at $111.99 on Tuesday. The stock has a 50 day moving average price of $123.07 and a 200 day moving average price of $134.85. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The firm has a market capitalization of $31.65 billion, a P/E ratio of 24.72, a P/E/G ratio of 2.32 and a beta of 1.31.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same period last year, the company earned $1.31 EPS. The business’s revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be paid a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.52%.

Analyst Ratings Changes

A has been the topic of several recent research reports. TD Cowen decreased their price target on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. The Goldman Sachs Group began coverage on shares of Agilent Technologies in a research note on Tuesday, December 9th. They set a “buy” rating and a $170.00 price objective for the company. Wells Fargo & Company reduced their target price on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and increased their target price for the company from $155.00 to $160.00 in a research note on Monday, January 5th. Finally, Morgan Stanley lowered their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.